Identification of biologic-responsive phenotypes in elderly people with eosinophilic asthma
Open Access
- 22 November 2023
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 3 (1) , 100196
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Asthma in the elderly: a different disease?Breathe, 2016
- Characterization and redox mechanism of asthma in the elderlyOncotarget, 2016
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trialsThe Lancet Respiratory Medicine, 2015
- Mepolizumab Treatment in Patients with Severe Eosinophilic AsthmaNew England Journal of Medicine, 2014
- Dupilumab in Persistent Asthma with Elevated Eosinophil LevelsNew England Journal of Medicine, 2013
- Asthma in the elderlyAsia Pacific Allergy, 2012
- Mepolizumab and Exacerbations of Refractory Eosinophilic AsthmaNew England Journal of Medicine, 2009
- Mepolizumab for Prednisone-Dependent Asthma with Sputum EosinophiliaNew England Journal of Medicine, 2009
- Age-Related Changes in Eosinophil Function in Human SubjectsChest, 2008
- Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthmaJournal of Allergy and Clinical Immunology, 2001